Intuitive Surgical, Inc. $ISRG Stock: Profund Advisors LLC Decreases Stake

Profund Advisors LLC cut its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.9% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 26,617 shares of the medical equipment provider’s stock after selling 1,960 shares during the quarter. Profund Advisors LLC’s holdings in Intuitive Surgical were worth $10,823,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. Bank of America Corp DE grew its stake in shares of Intuitive Surgical by 3.3% during the 1st quarter. Bank of America Corp DE now owns 3,616,973 shares of the medical equipment provider’s stock valued at $1,667,388,000 after acquiring an additional 116,292 shares during the period. Bank of New York Mellon Corp bought a new position in shares of Intuitive Surgical in the second quarter worth about $1,335,753,000. Amundi increased its position in Intuitive Surgical by 8.6% during the 1st quarter. Amundi now owns 2,428,356 shares of the medical equipment provider’s stock valued at $1,119,448,000 after purchasing an additional 193,096 shares during the period. Arrowstreet Capital Limited Partnership grew its position in shares of Intuitive Surgical by 95.3% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,105,544 shares of the medical equipment provider’s stock worth $970,635,000 after buying an additional 1,027,475 shares during the last quarter. Finally, Janus Henderson Group PLC increased its stake in Intuitive Surgical by 3.7% during the 1st quarter. Janus Henderson Group PLC now owns 1,643,060 shares of the medical equipment provider’s stock valued at $757,489,000 after purchasing an additional 58,587 shares in the last quarter. Institutional investors own 83.64% of the company’s stock.

Analyst Ratings Changes

A number of analysts have recently commented on ISRG shares. UBS Group restated a “buy” rating on shares of Intuitive Surgical in a research report on Tuesday, October 13th. Truist Financial decreased their price target on shares of Intuitive Surgical from $580.00 to $510.00 and set a “buy” rating for the company in a research note on Thursday, July 16th. Leerink Partners set a $503.00 target price on Intuitive Surgical and gave the company an “outperform” rating in a report on Wednesday, October 21st. Sanford C. Bernstein reissued an “outperform” rating on shares of Intuitive Surgical in a research report on Wednesday, August 12th. Finally, KeyCorp reiterated an “overweight” rating on shares of Intuitive Surgical in a report on Wednesday, August 12th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-three have assigned a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Intuitive Surgical has an average rating of “Moderate Buy” and a consensus price target of $493.54.

Intuitive Surgical Stock Down 3.7%

ISRG opened at $432.01 on Friday. The stock has a fifty day moving average of $401.54 and a 200-day moving average of $434.05. Intuitive Surgical, Inc. has a 12-month low of $328.57 and a 12-month high of $603.88. The firm has a market capitalization of $149.75 billion, a P/E ratio of 52.24, a PEG ratio of 2.98 and a beta of 1.46.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Tuesday, October 20th. The medical equipment provider reported $3.00 EPS for the quarter, beating analysts’ consensus estimates of $2.65 by $0.35. Intuitive Surgical had a return on equity of 18.17% and a net margin of 25.54%. The business had revenue of $3.05 billion for the quarter, compared to analyst estimates of $2.91 billion. During the same quarter in the prior year, the firm posted $2.40 EPS. The firm’s revenue for the quarter was up 21.7% on a year-over-year basis. On average, analysts expect that Intuitive Surgical, Inc. will post 9.37 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Intuitive Surgical news, SVP Patricia Wadors sold 1,078 shares of Intuitive Surgical stock in a transaction dated Friday, October 23rd. The stock was sold at an average price of $443.80, for a total value of $478,416.40. The transaction was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, VP Fredrik Widman sold 4,047 shares of the firm’s stock in a transaction dated Friday, October 23rd. The stock was sold at an average price of $453.21, for a total transaction of $1,834,140.87. Following the sale, the vice president owned 1,026 shares of the company’s stock, valued at approximately $464,993.46. This represents a 79.78% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 38,778 shares of company stock worth $16,814,967 over the last 90 days. 0.60% of the stock is currently owned by corporate insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops and manufactures robotic-assisted systems and related technologies for minimally invasive surgery. Its products are designed to help surgeons perform procedures through small incisions while providing enhanced visualization, precision and control. The company’s primary platform is the da Vinci Surgical System, which is used across a range of specialties, including urology, gynecology, general surgery, cardiothoracic surgery and other procedures.

The company also offers the Ion endoluminal system, which is designed to support minimally invasive lung biopsy procedures.